Prostaglandin E2 promotes endothelial differentiation from bone marrow-derived cells through AMPK activation

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Zhu, Zhenjiu ^a   Fu, Chenglai ^a   Li, Xiaoxia ^a   Song, Yimeng ^a   Li, Chenghong ^a   Zou, Minghui ^b   Guan, Youfei ^a   Zhu, Yi ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; BIOLOGICAL MARKER; CD31 ANTIGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE A; GELATINASE B; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; VON WILLEBRAND FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PROTEIN KINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR BINDING; UPREGULATION; ANIMAL; C57BL MOUSE; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; METABOLISM;

MUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; DINOPROSTONE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN KINASES; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;

EID: 80051845830     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023554     Document Type: Article

References (46)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
2. Ribatti D, (2007) The discovery of endothelial progenitor cells. An historical review. Leuk Res 31: 439-444.
3. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438.
4. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, et al. (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11: 261-262.
5. Ueno T, Suzuki T, Oikawa A, Hosono K, Kosaka Y, et al. (2010) Recruited bone marrow cells expressing the EP3 prostaglandin E receptor subtype enhance angiogenesis during chronic inflammation. Biomed Pharmacother 64: 93-100.
6. Rao R, Redha R, Macias-Perez I, Su Y, Hao C, et al. (2007) Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J Biol Chem 282: 16959-16968.
7. Reihill JA, Ewart MA, Hardie DG, Salt IP, (2007) AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem Biophys Res Commun 354: 1084-1088.
8. Stahmann N, Woods A, Spengler K, Heslegrave A, Bauer R, et al. (2010) Activation of AMP-activated protein kinase by vascular endothelial growth factor mediates endothelial angiogenesis independently of nitric-oxide synthase. J Biol Chem 285: 10638-10652.
9. Nagata D, Mogi M, Walsh K, (2003) AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 278: 31000-31006.
10. Webler AC, Michaelis UR, Popp R, Barbosa-Sicard E, Murugan A, et al. (2008) Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. Am J Physiol Cell Physiol 295: C1292-1301.
11. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, et al. (2004) Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 279: 28670-28674.
12. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, et al. (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309.
13. Li X, Han Y, Pang W, Li C, Xie X, et al. (2008) AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1789-1795.
14. Wang L, Zheng J, Bai X, Liu B, Liu CJ, et al. (2009) ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 104: 688-698.
15. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, et al. (2006) AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 26: 1281-1287.
16. Pino MS, Nawrocki ST, Cognetti F, Abruzzese JL, Xiong HQ, et al. (2005) Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells. Cancer Biol Ther 4: 1263-1269.
17. Ansari KM, Sung YM, He G, Fischer SM, (2007) Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin. Carcinogenesis 28: 2063-2068.
18. Steinert D, Kuper C, Bartels H, Beck FX, Neuhofer W, (2009) PGE2 potentiates tonicity-induced COX-2 expression in renal medullary cells in a positive feedback loop involving EP2-cAMP-PKA signaling. Am J Physiol Cell Physiol 296: C75-87.
19. Subbaramaiah K, Hudis C, Chang SH, Hla T, Dannenberg AJ, (2008) EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange. J Biol Chem 283: 3433-3444.
20. Li Calzi S, Neu MB, Shaw LC, Kielczewski JL, Moldovan NI, et al. (2010) EPCs and pathological angiogenesis: when good cells go bad. Microvasc Res 79: 207-216.
21. Kirton JP, Xu Q, (2010) Endothelial precursors in vascular repair. Microvascular research 79: 193-199.
22. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, et al. (2009) Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114: 723-732.
23. Kim H, Cho HJ, Kim SW, Liu B, Choi YJ, et al. (2010) CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circulation research 107: 602-614.
24. Yang J, Ii M, Kamei N, Alev C, Kwon SM, et al. (2011) CD34 Cells Represent Highly Functional Endothelial Progenitor Cells in Murine Bone Marrow. PloS one 6: e20219.
25. Marrotte EJ, Chen DD, Hakim JS, Chen AF, (2010) Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. The Journal of clinical investigation 120: 4207-4219.
26. Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, et al. (2006) Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 114: 2261-2270.
27. Ii M, Takeshita K, Ibusuki K, Luedemann C, Wecker A, et al. (2010) Notch signaling regulates endothelial progenitor cell activity during recovery from arterial injury in hypercholesterolemic mice. Circulation 121: 1104-1112.
28. Kwon SM, Eguchi M, Wada M, Iwami Y, Hozumi K, et al. (2008) Specific Jagged-1 signal from bone marrow microenvironment is required for endothelial progenitor cell development for neovascularization. Circulation 118: 157-165.
29. Kamoshita E, Ikeda Y, Fujita M, Amano H, Oikawa A, et al. (2006) Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol 169: 1458-1472.
30. Minami E, Laflamme MA, Saffitz JE, Murry CE, (2005) Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112: 2951-2958.
31. Kaye DM, Esler MD, (2006) Letter by Kaye and Esler regarding article "extracardiac progenitor cells repopulate most major cell types in the transplanted human heart". Circulation 113: e844; author reply e845.
32. Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, et al. (2002) Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 30: 967-972.
33. Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, et al. (2010) CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci U S A 107: 11008-11013.
34. Jin F, Zhai Q, Qiu L, Meng H, Zou D, et al. (2008) Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant 42: 581-588.
35. Cui X, Chen J, Zacharek A, Li Y, Roberts C, et al. (2007) Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke. Stem Cells 25: 2777-2785.
36. Uefuji K, Ichikura T, Mochizuki H, (2000) Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 6: 135-138.
37. Fukuda R, Kelly B, Semenza GL, (2003) Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res 63: 2330-2334.
38. Yanni SE, Barnett JM, Clark ML, Penn JS, (2009) The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest Ophthalmol Vis Sci 50: 5479-5486.
39. Finetti F, Donnini S, Giachetti A, Morbidelli L, Ziche M, (2009) Prostaglandin E(2) primes the angiogenic switch via a synergic interaction with the fibroblast growth factor-2 pathway. Circ Res 105: 657-666.
40. Faour WH, Gomi K, Kennedy CR, (2008) PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism. Cell Signal 20: 2156-2164.
41. Funahashi K, Cao X, Yamauchi M, Kozaki Y, Ishiguro N, et al. (2009) Prostaglandin E2 negatively regulates AMP-activated protein kinase via protein kinase A signaling pathway. Prostaglandins Other Lipid Mediat 88: 31-35.
42. Xie C, Liang B, Xue M, Lin AS, Loiselle A, et al. (2009) Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol 175: 772-785.
43. Ogawa Y, Suzuki T, Oikawa A, Hosono K, Kubo H, et al. (2009) Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth. Biochem Biophys Res Commun 382: 720-725.
44. Tsuji T, Aoshiba K, Yokohori N, Nagai A, (2009) A systemically administered EP2 receptor agonist stimulates pulmonary angiogenesis in a murine model of emphysema. Prostaglandins Other Lipid Mediat 90: 85-88.
45. Segi E, Sugimoto Y, Yamasaki A, Aze Y, Oida H, et al. (1998) Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 246: 7-12.
46. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, et al. (1997) The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390: 78-81.